Endovascular Stent Grafts Market Size, Sales, Average Price and Trends Analysis, till 2032

Endovascular Stent Grafts Market Size is estimated to be $1250 million in 2024 and is expected to grow at an average yearly rate of around 7% during the timeframe (2025-2032).

Monitor Country-wise Endovascular Stent Grafts Sales and Demand with Our Comprehensive Endovascular Stent Grafts Sales Database

Gain in-depth insights into the Endovascular Stent Grafts Sales landscape across United States, Germany, France, UK and 20+ countries with our specialized Endovascular Stent Grafts Sales Database. Stay ahead in the market by tracking country-wise Endovascular Stent Grafts Sales, identifying key manufacturers.

Extensive Endovascular Stent Grafts Sales database covering United States, Germany, France, UK and 20+ countries worldwide, Endovascular Stent Grafts Sales trends

Endovascular Stent Grafts market revenue tracker by country: United States, Germany, France, UK and 20+ countries worldwide

Stay Updated with Endovascular Stent Grafts Sales Trends

Track real-time Endovascular Stent Grafts prices, analyze Endovascular Stent Grafts price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Endovascular Stent Grafts Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/endovascular-stent-grafts-market/



Endovascular Stent Grafts sales trend in 2024 vs 2025

The sales trend of endovascular stent grafts has shown a noticeable increase from 2024 to 2025, driven by a combination of demographic, clinical, and technological factors. This market segment, which focuses on minimally invasive treatments for vascular diseases such as abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), has been gaining momentum due to its clinical advantages and rising global demand for advanced medical interventions.

In 2024, the market for endovascular stent grafts was already on a steady upward trajectory. Several drivers were behind this, including a global increase in the aging population, rising prevalence of cardiovascular diseases, and the need for procedures that reduce hospital stays and recovery times. Endovascular stent grafts meet these needs well-they are designed to be implanted via a catheter, allowing for faster recovery compared to traditional open surgery. Hospitals and surgical centers have increasingly preferred these minimally invasive solutions because they reduce procedural risk and lower the overall cost of care in the long term.

By 2025, this upward trend has become more pronounced. Sales have surged, reflecting a growing confidence among clinicians and healthcare systems in the technology's safety and effectiveness. One of the primary reasons for this spike in demand is the greater awareness and early diagnosis of aortic diseases, particularly in developed and emerging economies. As diagnostic imaging becomes more widely used, conditions like aneurysms are detected earlier, creating more opportunities for preventive interventions such as stent graft placement.

Another crucial contributor to the sales growth in 2025 is technological advancement. Manufacturers have introduced next-generation stent grafts that offer better flexibility, conformability to complex anatomies, and longer durability. Some newer models are specifically designed to address challenges like tortuous vessels or narrow access routes, broadening the eligible patient population. Additionally, digital technologies are playing a role-preoperative planning software, AI-guided navigation, and 3D imaging tools have improved the precision of these interventions, encouraging broader adoption by vascular surgeons and interventional radiologists.

The regulatory environment has also contributed to this trend. In many countries, health authorities have expedited the approval process for life-saving devices like endovascular stent grafts, especially when clinical data supports improved patient outcomes. This has allowed newer products to enter the market faster, giving healthcare providers more options and encouraging competitive pricing.

Furthermore, global healthcare investment continues to expand, particularly in emerging regions. Countries in Asia, the Middle East, and South America are upgrading their healthcare infrastructure and increasingly adopting modern, less invasive treatment technologies. This trend has opened up new markets for stent graft manufacturers, contributing significantly to the sales boost in 2025.

Request for customization https://datavagyanik.com/reports/endovascular-stent-grafts-market/



Endovascular Stent Grafts Market Definition

The endovascular stent grafts market refers to the global industry centered around the development, production, and distribution of stent graft devices used in endovascular procedures. Endovascular stent grafts are specialized medical implants designed to treat diseases of the vascular system, particularly aneurysms, by providing internal support to weakened or damaged blood vessels. These grafts are most commonly used to treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), which, if left untreated, can lead to life-threatening ruptures.

A stent graft is a tubular device composed of two main components: a synthetic graft material, typically made from fabrics such as polyester or expanded polytetrafluoroethylene (ePTFE), and a metal stent, often made from nitinol or stainless steel. The metal stent provides structural support, while the graft serves as a new inner lining for the artery. The combination of these two elements allows the stent graft to redirect blood flow and relieve pressure from the damaged section of the vessel, reducing the risk of rupture.

Unlike traditional open surgery, which involves a large incision and direct access to the affected artery, endovascular stent graft procedures are minimally invasive. The device is delivered through a catheter inserted into a small incision, usually in the groin. It is then guided through the arteries to the site of the aneurysm or lesion using imaging techniques such as fluoroscopy. Once positioned correctly, the stent graft is deployed to reinforce the vessel wall and restore normal blood flow.

The market for endovascular stent grafts includes a wide range of stakeholders, such as medical device manufacturers, hospitals, surgical centers, research institutions, and regulatory agencies. It encompasses all activities related to research and development, clinical trials, regulatory approvals, manufacturing, marketing, sales, and post-market surveillance of these devices.

Key segments within the market are often categorized by product type, anatomical application, and end user. Product types may include aortic stent grafts, thoracic stent grafts, fenestrated and branched stent grafts, and iliac branch devices. Anatomical applications refer to the specific parts of the vascular system where these grafts are used-abdominal aorta, thoracic aorta, and peripheral vessels. End users include hospitals, ambulatory surgical centers, and specialty vascular clinics.

The growth of the endovascular stent graft market is largely driven by the increasing incidence of vascular diseases, advancements in imaging and catheter technologies, growing preference for minimally invasive procedures, and improving access to healthcare in both developed and developing regions. Aging populations and greater awareness of vascular health have also contributed to rising demand.

Important target segments driving the demand for Endovascular Stent Grafts Market

The demand for endovascular stent grafts is driven by several key target segments, each playing a crucial role in expanding the reach and impact of these life-saving devices. These segments include specific patient populations, healthcare institutions, medical specialties, and geographic markets that are particularly affected by vascular diseases and have the infrastructure or demand for minimally invasive treatment options.

1. Aging Population:
One of the most important target segments driving demand is the elderly population. As people age, the risk of developing vascular conditions such as abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA) increases significantly. These conditions often remain asymptomatic until they become life-threatening. Older adults are more likely to benefit from endovascular procedures because these techniques offer shorter recovery times and reduced surgical risks compared to open surgery. This makes the elderly an ideal target group, especially in developed countries with aging populations like the U.S., Japan, and countries in Europe.

2. Patients with High Surgical Risk:
Another critical target segment includes patients who are considered high-risk for traditional open surgery. This group may include individuals with multiple comorbidities such as diabetes, hypertension, chronic kidney disease, or poor cardiovascular health. For these patients, open surgery poses substantial risks, while endovascular procedures offer a safer alternative with less anesthesia, shorter hospital stays, and fewer postoperative complications. The availability of advanced stent grafts specifically designed for difficult anatomies further supports this segment.

3. Hospitals and Specialized Surgical Centers:
Medical institutions, particularly those equipped with advanced vascular surgery departments and interventional radiology units, form a vital segment driving demand. These centers not only perform a high volume of endovascular procedures but also often participate in clinical trials and technology adoption. Teaching hospitals and urban medical centers tend to be early adopters of new medical devices, making them key partners for manufacturers aiming to introduce next-generation stent grafts.

4. Vascular and Endovascular Surgeons:
The growing specialization within the medical community has made vascular and endovascular surgeons a key target segment. These professionals are trained in both diagnosis and treatment of complex vascular conditions and play a major role in determining the choice of intervention. Their preferences influence procurement decisions at hospitals, making them a primary target for device manufacturers through medical education programs, product demonstrations, and peer-reviewed evidence.

5. Emerging Economies:
Geographic regions experiencing healthcare expansion, such as Southeast Asia, Latin America, and parts of the Middle East, represent fast-growing market segments. These regions are investing heavily in medical infrastructure and technology, which opens the door for the adoption of modern treatment options like endovascular stent grafts. Rising incomes, urbanization, and greater access to healthcare services in these areas are driving demand among both patients and institutions.

6. Government and Defense Health Systems:
Public healthcare systems and military health organizations also form a significant target segment. Governments often seek cost-effective, efficient treatment solutions for vascular diseases affecting large populations, including veterans and public service employees. Public tenders for medical devices and reimbursement schemes further support adoption in this segment.



Key Players in Endovascular Stent Grafts, Market Share: United States and global market

The endovascular stent grafts market is shaped by a relatively small group of dominant companies that hold a significant share both in the United States and globally. These key players are instrumental in setting the pace of innovation, expanding access to minimally invasive vascular treatments, and defining the competitive landscape of the industry.

United States Market:

In the United States, the market for endovascular stent grafts is highly consolidated, with a few companies controlling a majority of the market share. Medtronic is widely recognized as the market leader due to its comprehensive product offerings, early market entry, and ongoing innovation. Its stent graft systems for both abdominal and thoracic aortic aneurysms have been widely adopted in U.S. hospitals and surgical centers. The company's deep relationships with vascular surgeons and its long-standing reputation for reliability give it a significant competitive edge.

Close behind is W. L. Gore & Associates, an American company known for its durable and biocompatible stent graft materials. Gore's products are trusted for their quality and longevity, particularly in complex aortic procedures. The company continues to innovate with grafts designed to address challenging anatomies, which has helped it retain a strong share of the U.S. market.

Cook Medical also holds a notable position in the U.S. market. As one of the pioneers of endovascular therapy, Cook Medical has built a strong base of clinical evidence supporting its devices. It has remained competitive through ongoing investment in R&D and a strong commitment to physician training.

Global Market:

Globally, the market is slightly more fragmented, but the same major players maintain a leading presence. Medtronic, W. L. Gore, and Cook Medical remain dominant in Europe, Australia, and parts of Asia. Their well-established international distribution networks, regulatory compliance capabilities, and partnerships with healthcare providers support their leadership on a global scale.

Boston Scientific, while not always the primary leader in this segment, has increased its presence through acquisitions and expanded product offerings, especially in emerging markets. Its global infrastructure and reputation across various medical device fields allow it to enter and compete in the endovascular space effectively.

Asian manufacturers, particularly Terumo Corporation from Japan and MicroPort Scientific Corporation from China, are expanding their presence in the global market. Terumo has gained respect for high-quality stent grafts and has leveraged Japan's advanced healthcare infrastructure as a springboard into international markets. MicroPort has focused on expanding in developing regions and has seen strong growth in Asia, Latin America, and parts of Eastern Europe.

Endologix LLC, though smaller in size, specializes in niche segments of the stent graft market and has been recognized for developing unique solutions for complex aneurysm cases. Its innovation-focused model helps it stand out among larger players.



Key Questions Answered in the Endovascular Stent Grafts market report:

What is the total global and United States Endovascular Stent Grafts Sales volume, and how has it changed over the past five years?

What is Endovascular Stent Grafts price trend, what has been the historical prices in United States and other countries?

What will be the Endovascular Stent Grafts price trend in 2025?

United States Endovascular Stent Grafts Sales, and what factors contribute to their dominance in the market?

How does Endovascular Stent Grafts Sales vary across key manufacturers, and what expansions have been observed recently?

What is the revenue generated from Endovascular Stent Grafts Sales, and how does it compare to previous years, in the United States and other parts of the world?

Which industries drive the highest demand for Endovascular Stent Grafts, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Endovascular Stent Grafts Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Endovascular Stent Grafts Sales and market dynamics?

Related Studies:

Thoracic Stent garft Market
https://datavagyanik.com/reports/thoracic-stent-garft-market/

ePTFE Vascular Graft Market
https://datavagyanik.com/reports/eptfe-vascular-graft-market/

Peripheral Vascular Grafts Market
https://datavagyanik.com/reports/peripheral-vascular-grafts-market/

Vascular Grafts for Aorta Disease Market

https://datavagyanik.com/reports/vascular-grafts-for-aorta-disease-market/

Coronary Artery By-Pass Grafts Market
https://datavagyanik.com/reports/coronary-artery-by-pass-grafts-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.